Invited commentary: Gene × lifestyle interactions and complex disease traits - Inferring cause and effect from observational data, sine qua non

American Journal of Epidemiology

Volumn 172, Issue 9, 2010, Pages 992-997

  Franks, Paul W ^a,b   Nettleton, Jennifer A ^c  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CDKAL1 protein, human; energy intake; hemoglobin A1c protein, human; Japan; metabolic syndrome X

Indexed keywords

HEMOGLOBIN A1C;

CALORIC INTAKE; CDKAL1 GENE; COHORT ANALYSIS; DIETARY INTAKE; FOOD COMPOSITION; GENE; GENE LOCUS; GENETIC TRAIT; HUMAN; JAPANESE; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY;

ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIN-DEPENDENT KINASE 5; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; GENETIC MARKERS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; METABOLIC SYNDROME X; PREVALENCE; QUESTIONNAIRES;

EID: 77958548114     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq280     Document Type: Note

References (35)

1. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
2. Miyaki K, Oo T, Song Y, et al. Association of a cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like 1 (CDKAL1) polymorphism with elevated hemoglobin A1c levels and the prevalence of metabolic syndrome in Japanese men: interaction with dietary energy intake. Am J Epidemiol. 2010;172(9):985-991.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
4. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18): 1343-1350. (Pubitemid 32378388)
5. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16): 1117-1124.
6. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001; 33(6 suppl):S446-S451.
7. Franks PW, Jablonski KA, Delahanty L, et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007;50(12): 2451-2460.
8. Lindi VI, Uusitupa MI, Lindström J, et al. Association of the Pro12Ala polymorphism in the PPAR-c2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 2002;51(8): 2581-2586.
9. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355(3):241-250.
10. Florez JC, Jablonski KA, McAteer J, et al. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia. 2008;51(3):451-457.
11. Franks PW, Mesa JL, Harding AH, et al. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2007;17(2):104-124.
12. Bray MS, Hagberg JM, Pérusse L, et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc. 2009;41(1):35-73.
13. Corella D, Peloso G, Arnett DK, et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med. 2009;169(20): 1897-1906.
14. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007;8(9):657-662.
15. Grant RW, Moore AF, Florez JC. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care. 2009;32(6):1107-1114.
16. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579-589.
17. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyc-eride levels. Science. 2007;316(5829):1331-1336.
18. Wellcome Trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
19. Horikoshi M, Hara K, Ito C, et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia. 2007;50(12): 2461-2466. (Pubitemid 350060646)
20. Franks PW, Bhattacharyya S, Luan J, et al. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10. Hypertension. 2004;43(2):224-228.
21. Leon AC, Heo M, Teres JJ, et al. Statistical power of multiplicity adjustment strategies for correlated binary endpoints. Stat Med. 2007;26(8):1712-1723.
22. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev. 2005;14(12):2826-2828.
23. Willett WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
24. Subar AF, Kipnis V, Troiano RP, et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN Study. Am J Epidemiol. 2003;158(1): 1-13.
25. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120-132.
26. Palla L, Higgins JP, Wareham NJ, et al. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol. 2010;171(11):1225-1232.
27. Moore AF, Jablonski KA, McAteer JB, et al. Extension of type 2 diabetes genome-wide association scan results in the Diabetes Prevention Program. Diabetes. 2008;57(9):2503-2510.
28. Ruchat SM, Rankinen T, Weisnagel SJ, et al. Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study. Diabetologia. 2010;53(4): 679-689.
29. Brito EC, Lyssenko V, Renström F, et al. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. Diabetes. 2009; 58(6):1411-1418.
30. Melanson KJ, Westerterp-Plantenga MS, Saris WH, et al. Blood glucose patterns and appetite in time-blinded humans: carbohydrate versus fat. Am J Physiol. 1999;277(2):R337-R345.
31. Ubeda M, Rukstalis JM, Habener JF. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem. 2006;281(39):28858-28864.
32. Livingstone MB, Black AE. Markers of the validity of reported energy intake. J Nutr. 2003;133(suppl 3):895S-920S.
33. Luan J, Browne PO, Harding AH, et al. Evidence for gene-nutrient interaction at the PPARc locus. Diabetes. 2001;50(3): 686-689.
34. Sonestedt E, Roos C, Gullberg B, et al. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr. 2009;90(5):1418-1425.
35. Franks PW, Jablonski KA, Delahanty LM, et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2008;51(12):2214-2223.